You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 9,056,137


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,056,137
Title:Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
Abstract: The present invention provides thermo-sensitive, mucoadhesive biopolymer formulations that enhance the penetration of therapeutics across the skin or mucosal surfaces. In a preferred embodiment, the biopolymer formulation comprises co-polymer of poloxamer 188 and propylene glycol, laurocapram and, optionally, one or more therapeutic agents. Also provided are uses of the biopolymer formulations for topical therapy of cancer including cervical cancer.
Inventor(s): Hsu; Stephen I-Hong (Gainesville, FL)
Assignee: UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (Gainesville, FL)
Application Number:14/008,004
Patent Claims:1. A composition for topical delivery of therapeutics across the skin or mucosal surfaces, the composition comprising poloxamer 188, propylene glycol, laurocapram and a therapeutic agent, wherein the therapeutic agent is a cytotoxic decoy peptide, unfractionated and low molecular weight heparins selected from ardeparin, bemiparin, certoparin, dalteparin, enoxaparin, nadroparin, parnaparin, reviparin, tinzaparin, fondaparinux, idraparinux sodium, rivaroxaban, apixaban, lepirudin, bivalirudin, argatroban, dabigatran warfarin, acenocoumarol or phenprocoumon, a Factor Xa inhibitor selected from fondaparinux, idraparinux sodium, rivaroxaban, or apixaban, a direct thrombin inhibitor selected from lepirudin, bivalirudin, argatroban, or dabigatran, or a vitamin K antagonist selected from warfarin, acenocoumarol or phenprocoumon.

2. A method for topical, non-invasive delivery of therapeutic agents, the method comprising administering, to skin or mucosal surface of a subject, a composition according to claim 1.

3. A composition for topical delivery of therapeutics across the skin or mucosal surfaces, the composition comprising poloxamer 188 propylene glycol laurocapram and a therapeutic agent, wherein the therapeutic agent is selected from decoy peptides, chemotherapeutic agents, anti-cancer or anti-tumor agents, antibiotics, anti-bacterial agents, anti-viral agents, anti-fungal agents, anti-microbial agents, anti-neoplastic agents, immunomodulatory agents, anti-inflammatory agents, cytokines, chemokines or interleukins.

4. The composition according to claim 3, wherein the therapeutic agent is one or more chemotherapeutic agent selected from: 5-fluorouracil, chlorambucil, aminolevulinic acid, altretamine, ambomycin, vincristine, buthionine sulfoximine, asparaginase, bleomycin, busulin, trimetrexate, adriamycin, taxotere, carboplatin, cisplatin, carmustine, cladribine, 5-ethynyluracil, 9-dihydrotaxol, mitomycin, abiraterone, acivicin, teniposide, aclarubicin, acodazole hydrochloride, canarypox IL-2, acronine, thioguanine, acylfulvene, adecypenol, adozelesin, aldesleukin, thiotepa, ambamustine, busulfan, ametantrone acetate, amidox, amrubicin, mercaptopurine, cyclophosphamide, cytarabine, paclitaxel pentostatin, dacarbazine, dactinomycin, daunorubicin, camptothecin derivatives, doxorubicin, etoposide, fludarabine phosphate, hydroxyurea, BRC/ABL antagonists, breflate, brequinar sodium, bropirimine, budotitane, amifostine, actinomycin, calcipotriol, calphostin C, calusterone, caracemide, carbetimer, floxuridine, idarubicin, ifosfamide, lomustine, mechlorethamine, melphalan, methotrexate, mitoxantrone, pliamycin, procarbazine, streptozocin or vinblastine.

5. A method for topical therapy of cancer, the method comprising administering to skin or a mucosal surface of a subject in need of such treatment, a composition according to claim 4.

6. The method according to claim 5, wherein the composition comprises poloxamer 188, propylene glycol, laurocapram and the therapeutic agent.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.